期刊文献+

血肿抽吸术对脑出血后早期基质金属蛋白酶-9的影响 被引量:2

Effect of hematoma aspiration on matrix metalloproteinase-9 after intracerebral hemorrhage
下载PDF
导出
摘要 目的探讨血肿抽吸术治疗脑出血对患者血清基质金属蛋白酶-9水平的影响。方法选择脑出血患者60例的临床资料进行回顾性分析,其中30例采用血肿抽吸术治疗为研究组,30例采用保守治疗为对照组,比较2组治疗前后血清MMP-9水平,分析MMP-9与NDS的相关性,以及患者的预后情况。结果 2组血清MMP-9水平均在治疗后2d达到高峰,但研究组的高峰值显著低于对照组,差异有统计学意义(P<0.01);随后MMP-9水平逐渐下降,但研究组治疗后7d及14dMMP-9水平均显著低于对照组,差异有统计学意义(P<0.01)。2组治疗后NDS评分均显著低于入院时,差异有统计学意义(P<0.01);研究组治疗第14天研究组NDS评分显著低于对照组,差异有统计学意义(P<0.01)。研究组和对照组血清MMP-9水平与NDS评分具有显著的正相关性(P<0.01)。研究组总有效率90.0%,对照组为63.3%,研究组显著高于对照组,差异有统计学意义(P<0.05)。结论脑出血患者采用血肿抽吸术治疗,治疗后能够显著降低MMP-9的高峰值,有利于改善患者的预后。 Objective To explore the effect of hematoma aspiration on matrix metalloproteinase-9 (MMP-9) after intracerebral hemorrhage. Methods Clinical data of 60 patients with intracerebral hemorrhage were collected and analyzed re- spectively. 30 cases were treated with hematoma aspiration as study group,another 30 cases of control group were treated with medications. MMP-9 levels of two groups before and after treatment were collected and compared, relationships between MMP-9 and NDS (neurological functional defect scale score) as well as clinical efficacy were observed. Results MMP-9 levels in the serum of both groups reached the peaks after 2 days with treatments, but the MMP-9 peak level of study group was significantly lower than that of control group (P〈0.01) ;However, MMP-9 levels of both groups decreased, but MMP-9 levels of study group were significantly lower than that of control group at the day 7 and day 14 following intracerebral hemorrhage (P 〈0.01). NDS scores in both groups after treatment were significantly lower than those before treatment (P%0.01). After treatment, NDS scores of study group were significantly lower than that of control group (P〈0.01). MMP-9 levels in serum showed positive correlation with NDS (P〈0.01). Total efficacy rate of study group was 90.0%, and control group was 63.3%, which showed significant difference (P〈0.05). Conclusion Hematoma aspiration for intracerebral hemorrhage can reduce MMP-9 peak level, which may help to improve the prognosis of patients with intracerebral hemorrhage.
出处 《中国实用神经疾病杂志》 2016年第14期8-10,共3页 Chinese Journal of Practical Nervous Diseases
基金 国家自然科学基金面上项目(81471174)
关键词 血肿抽吸术 脑出血 基质金属蛋白酶-9 Hematoma aspiration Cerebral hemorrhage MMP-9
  • 相关文献

参考文献13

二级参考文献106

  • 1田力,杨艳敏,何平.实验性脑出血后MMP-9表达的意义[J].中国老年学杂志,2006,26(3):382-383. 被引量:4
  • 2Chu CS,Lee KT,Lee MY,菅鑫妍.罗格列酮单用或者与阿伐他汀联合使用对于2型糖尿病患者心血管疾病的非传统标志物的作用[J].中国处方药,2006(6):24-25. 被引量:11
  • 3田培超,王怀立.MMP-9及TIMP-1在大鼠感染性脑水肿的表达及意义[J].中国实用神经疾病杂志,2007,10(2):9-11. 被引量:7
  • 4GascheY, Copin JC, Sugawara T, et al. Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia[ J]. J cereb Blood Flow M etab, 2001, 21: 1393 - 1400.
  • 5VisseR, NagaseH. Matrix metalloproteinasesand tissue inhibitiors of metal- loproteinases structure, function, and biochemistry[J]. CiRes, 2003, 92: 827 - 839.
  • 6RosellA, Ortega-AznarA, Alvarez-Sabin J, et al. Increased brainexpression of matrix metalloproteinase-9 after ischemic and hemor-rhagic human stroke[J]. Stroke, 2006, 37: 1399-1408.
  • 7Abilleira S, Montaner J, MolinaCA, et al. Matrix metalloproteinase concentration after spontaneous intracerebral hemorrhage [ J ]. JNeurosurg, 2003, 99:65 - 70.
  • 8Alvarez-Sabin J,Delgado P, Abilleira S, et al. Temporal profile of matrixmetalloproteinases and their inhibitors after spontaneous in-tracerebralhemorrhage relationship to clinical and radiological out-come[ J]. Stroke, 2004, 35: 1316-1321.
  • 9RosenbergGA, NavratilM. Metalloproteinase inhibition blocks edema intracerebral hemorrhage in the rat[J]. Neurology, 1997, 48:921-926.
  • 10OpdenakkerG, Van-den-Steen PE, DuboisB, et al. Gelationase B functions as regulator and effector in leukocyte biology[J]. Leukoc Biol, 2001, 69: 851 - 859.

共引文献78

同被引文献6

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部